Ecolab Inc. ECL SPX

Q: What is the current share price of Ecolab Inc. (ECL)?

As of 2026-07-14 21:23 PDT, Ecolab Inc. (ECL) trades at $269.75 on NYSE. Its 52-week range is $245.06 to $306.69.

Q: What is the market capitalisation of ECL?

Ecolab Inc. (ECL) has a market capitalisation of $75.92B on NYSE.

Q: What is the P/E ratio of ECL?

ECL trades at a trailing price-to-earnings (P/E) ratio of 36.55. The industry average P/E is 22.91. Its price-to-book (P/B) ratio is 7.47.

Q: Does ECL pay a dividend?

Ecolab Inc. (ECL) currently offers a dividend yield of 1.10%.

Q: What is the return on equity (ROE) of ECL?

ECL has a return on equity (ROE) of 22.43%. Its return on capital employed (ROCE) is 14.29%.

Q: Is ECL a good stock to buy?

This page provides a data-driven analysis of Ecolab Inc. (ECL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Basic Materials · Specialty Chemicals · United States

https://www.ecolab.com

Company Profile ↓

$269.75

+1.64% 1Y

Mkt Cap$75.92B

P/E36.55

P/B7.47

Div. Yield1.10%

52W High$306.69

52W Low$245.06

Book Value$35.55

EPS (TTM)$7.38

Company Overview

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 22.4%, reflecting efficient use of shareholder capital.

Healthy Margins

Operating margin of 16.9% supports profitability.

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

Dec 2025 Revenue of $16.08B (+2.2% YoY); net profit $2.08B.
Trailing 12 Months Year-on-year growth — revenue +10.0%, earnings +7.8%.
5-Year Trend Long-term compounding — revenue CAGR 6.2%, profit CAGR 9.2%.

Growth & Price Performance

Compounded Sales Growth

5 Years:	6.17%
1 Year:	10.00%

Compounded Profit Growth

5 Years:	9.18%
1 Year:	7.80%

Stock Price Performance

1 Year:	+1.64%
6 Months:	-0.19%
3 Months:	-1.71%
1 Month:	+2.60%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish

52-Week Range 40% of range

$245.06 $306.69

Trend Signals

Price vs 50-DMAAbove
Price vs 200-DMAAbove
RSI (14)47.56 · Neutral

Price Performance

1M+2.60%

3M-1.71%

6M-0.19%

1Y+1.64%

Valuation vs Sector

P/E of 36.55 is above the sector median of 22.91 — pricier than peers.

Auto-generated from price history and fundamentals; not investment advice.

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Period: Metric:

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

Strong return on equity of 22.4%.
Generates positive free cash flow.

CONS

In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Valuation

Stock P/E

36.55

Industry PE

22.91

Forward P/E

28.09

PEG Ratio

2.46

Book Value

$35.55

Price to Book

7.47

P/S

4.54

EV/EBITDA

20.66

Dividend Yield

1.10%

Growth (CAGR)

Revenue 5Y

6.17%

Profit 5Y

9.18%

Revenue (YoY)

10.00%

Earnings (YoY)

7.80%

Profitability & Returns

ROCE

14.29%

ROE

22.43%

ROA

8.01%

Profit Margin

12.80%

Op Margin

16.93%

Gross Margin

44.37%

EPS (Latest Qtr)

$1.52

EPS (TTM)

$7.38

Balance Sheet & Liquidity

Debt/Equity

0.92

Quick Ratio

0.68

Current Ratio

0.99

Debt

$9.27B

Total Assets

$25.04B

Current Assets

$6.04B

Working Capital

$-53.00M

Ownership

Promoter Holding

0.15%

Chg in Prom Hold

FII / Inst Holding

93.83%

Chg in FII Hold

-0.12%

Financial Snapshot

Enterprise Value

$75.92B

Total Revenue (TTM)

$16.45B

EBITDA

$4.04B

Free Cash Flow

$1.59B

Operating Cash Flow

$3.03B

Shares Outstanding

281.44M

Gross Margin

44.37%

Payout Ratio

37.35%

Peer comparison

Peer companies in the same sector (Basic Materials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	ECL Ecolab Inc. SPX	269.75	36.55	$75.92B	1.10%	14.29%	22.43%	6.17%	9.18%
2	LIN Linde plc NDXSPX	522.54	34.65	$241.59B	1.22%	12.46%	18.23%	13.90%	18.47%
3	NEM Newmont Corporation SPX	94.75	12.29	$101.15B	1.04%	-	25.83%	6.53%	20.15%
4	FCX Freeport-McMoRan Inc. SPX	61.95	32.78	$89.06B	0.88%	12.50%	15.63%	1.35%	-1.26%
5	SHW The Sherwin-Williams Company SPX	328.50	31.56	$81.02B	1.01%	21.93%	60.72%	6.18%	8.26%
6	CRH CRH plc SPX	103.91	19.28	$69.43B	1.47%	10.97%	15.81%	6.41%	9.30%
7	APD Air Products and Chemicals, Inc. SPX	299.40	31.55	$66.67B	2.57%	-0.62%	12.35%	-1.77%	-39.16%
8	CTVA Corteva, Inc. SPX	84.91	45.90	$56.79B	0.95%	-	5.14%	2.86%	9.94%
9	DD DuPont de Nemours, Inc. SPX	134.17	353.08	$54.35B	1.66%	4.46%	0.90%	-19.27%	-37.76%

Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric	Mar 2016	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Revenue	-	-	-	-	3.16B	3.46B	3.56B	3.65B	3.47B	3.69B	3.75B	3.76B	2.92B	3.17B	3.22B	3.24B	3.02B	2.69B	3.02B	3.07B	2.88B	3.16B	3.32B	3.36B	3.27B	3.58B	3.67B	3.67B	3.57B	3.85B	3.96B	3.94B	3.75B	3.99B	4.00B	4.01B	3.69B	4.03B	4.17B	4.07B
Operating Income	371.50M	412.50M	574.10M	556.90M	357.20M	419.60M	564.10M	609.20M	354.30M	494.60M	516.20M	581.90M	313.60M	464.40M	549.00M	518.20M	376.20M	192.00M	411.40M	416.10M	297.30M	447.80M	465.80M	387.70M	254.50M	425.80M	483.00M	399.20M	351.60M	484.70M	566.00M	590.00M	517.90M	656.90M	1.04B	582.80M	555.30M	710.10M	760.20M	622.00M
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	193.60M	310.80M	324.50M	-	171.90M	308.30M	347.10M	-	233.40M	329.70M	404.00M	-	412.10M	490.90M	736.50M	-	402.50M	524.20M	585.00M	432.60M
Diluted EPS	0.77	0.87	1.27	1.24	0.86	1.00	1.34	1.92	0.84	1.20	1.48	1.35	1.01	1.26	1.59	1.47	0.97	-6.98	0.85	1.04	0.67	1.08	1.12	1.04	0.60	1.08	1.21	0.93	0.82	1.15	1.41	1.41	1.43	1.71	2.58	1.66	1.41	1.84	2.05	1.52

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	5.47B	6.14B	5.90B	6.09B	6.80B	11.84B	13.25B	14.28B	13.55B	13.15B	13.84B	12.22B	12.56B	11.79B	12.73B	14.19B	15.32B	15.74B	16.08B
Operating Income	669.00M	712.80M	681.30M	806.80M	753.80M	1.29B	1.56B	1.96B	1.56B	1.87B	1.95B	1.73B	1.85B	1.40B	1.60B	1.56B	1.99B	2.80B	2.74B
Net Income	427.20M	448.10M	417.30M	530.30M	462.50M	703.60M	967.80M	1.20B	1.00B	1.23B	1.50B	1.43B	1.56B	-1.21B	1.13B	1.09B	1.37B	2.11B	2.08B
Diluted EPS	1.70	1.80	1.74	2.23	1.91	2.35	3.16	3.93	3.32	4.14	5.12	4.88	5.33	-4.15	3.91	3.81	4.79	7.37	7.28
R&D Expense	-	86.00M	86.00M	88.00M	96.00M	183.00M	188.00M	197.00M	191.00M	189.00M	201.00M	193.00M	190.00M	185.00M	186.00M	190.00M	192.00M	207.00M	202.00M

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	4.76B	5.02B	4.87B	18.18B	17.57B	19.64B	19.43B	18.64B	18.33B	19.96B	20.07B	20.87B	18.13B	21.21B	21.46B	21.85B	22.39B	24.70B
Total Equity	1.69B	1.94B	1.57B	2.00B	2.13B	5.67B	6.08B	7.34B	7.32B	6.91B	6.90B	7.58B	8.00B	8.69B	6.17B	7.22B	7.24B	8.04B	8.76B	9.77B
Cash & Equivalents	484.00M	137.40M	66.70M	73.60M	242.30M	1.84B	1.16B	339.20M	209.60M	92.80M	327.40M	211.40M	114.70M	118.80M	1.26B	359.90M	598.60M	919.50M	1.26B	646.20M
Long Term Debt	-	-	799.30M	868.80M	656.40M	6.61B	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	-	-	-	12.44B	11.41B	12.23B	12.05B	11.66B	11.36B	12.31B	12.02B	12.14B	11.92B	13.95B	14.21B	13.77B	13.60B	14.89B
Current Liabilities	-	-	1.44B	1.25B	1.32B	3.17B	3.05B	3.49B	4.37B	4.76B	3.02B	3.48B	3.69B	3.63B	2.93B	3.55B	4.21B	4.35B	4.79B	5.53B

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	797.60M	753.20M	695.00M	950.40M	-	-	-	-	2.00B	1.94B	2.09B	2.28B	2.42B	1.86B	-	1.79B	2.41B	2.81B	2.95B
Investing Cash Flow	-663.70M	-580.70M	-299.30M	-303.60M	-	-	-	-	-915.80M	-773.60M	-1.73B	-1.03B	-1.20B	-414.50M	-	-716.80M	-990.50M	-433.80M	-2.71B
Financing Cash Flow	-482.40M	-235.60M	-397.80M	-462.20M	-	-	-	-	-1.15B	-868.20M	-522.70M	-1.17B	-1.35B	-341.80M	-	-837.30M	-1.05B	-2.02B	-853.30M
Capital Expenditure	-306.50M	-326.70M	-252.50M	-260.50M	-341.70M	-574.50M	-625.10M	-748.70M	-771.00M	-756.80M	-868.60M	-778.70M	-731.30M	-489.00M	-	-712.80M	-774.80M	-994.50M	-1.05B
Free Cash Flow	491.10M	426.50M	442.50M	689.90M	-	-	-	-	1.23B	1.18B	1.22B	1.50B	1.69B	1.37B	-	1.08B	1.64B	1.82B	1.90B
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	234.30M	366.60M	356.00M	-607.90M
Share Buybacks	371.40M	337.20M	68.80M	348.80M	690.00M	209.90M	307.60M	428.60M	755.10M	739.60M	600.30M	562.40M	353.70M	146.20M	106.60M	518.20M	13.70M	986.50M	783.80M

Ratios (Annual)

Figures in %.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Margin %	12.2%	11.6%	11.5%	13.2%	11.1%	10.9%	11.8%	13.7%	11.5%	14.2%	14.1%	14.1%	14.7%	11.8%	12.6%	11.0%	13.0%	17.8%	17.0%
Net Margin %	7.8%	7.3%	7.1%	8.7%	6.8%	5.9%	7.3%	8.4%	7.4%	9.3%	10.9%	11.7%	12.4%	-10.2%	8.9%	7.7%	9.0%	13.4%	12.9%
ROE %	22.0%	28.5%	20.9%	24.9%	8.2%	11.6%	13.2%	16.4%	14.5%	17.8%	19.8%	17.9%	17.9%	-19.5%	15.6%	15.1%	17.1%	24.1%	21.2%
ROCE %	-	21.5%	18.1%	22.7%	5.0%	8.9%	9.7%	13.0%	11.3%	12.2%	11.8%	10.5%	10.7%	9.2%	9.1%	9.1%	11.4%	15.9%	14.3%

Shareholding Pattern

Insiders

0.15%

Institutions

93.83%

Public Float

93.97%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	8.10%	22.81M	$6.38B
2	Vanguard Capital Management LLC	5.87%	16.52M	$4.62B
3	JPMORGAN CHASE & CO	4.14%	11.66M	$3.26B
4	State Street Corporation	3.99%	11.22M	$3.14B
5	Morgan Stanley	2.77%	7.79M	$2.18B
6	Vanguard Portfolio Management LLC	2.25%	6.32M	$1.77B
7	Geode Capital Management, LLC	2.13%	5.99M	$1.68B
8	Gates Foundation Trust	1.85%	5.22M	$1.46B
9	Aristotle Capital Management, LLC	1.32%	3.71M	$1.04B
10	UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1.27%	3.57M	$997.72M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ECL

Google News Sat, 04 Jul 2026

Ecolab (ECL) Stock Looks 30% Overvalued Despite AI Cooling Deal - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOcTBrXzVuQWJIMzFTTnFBaHNJLWFfbmY2cXNRbGpoUEJXNTlPMTQ2TWFxOVh2SHNLNnc5cmZFUHc5Q3dIV0U5aFVVMWRHNlBVUlZNMlh3Y1JfTUV5RktCZHpmTTFHS1VHZGFST0FBbTA5Q0RHaEM0OVhHY1hVRkxqQ2dnZ1JCaEhNNVhBX2…

Google News Sat, 04 Jul 2026

Ecolab (ECL) Stock Looks Pricey On Cash Flow And Earnings - simplywall.st

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQQWRJQl8zd25xM1FWclpTYy13T0ttTTJDS3RkbDhsRDJwWFpnb0l5djM4dGxveGNNM244RDRabWd6Mll5c1RlR0VuamdneGhBT3BBLUlkczM0TDBydVBXNnAzbW95Q3g4VmgyMDdvSW9pSzNvbEY1QUp1aW5QcEJHZzF3RS1EVmFxcE1YaV…

Google News Fri, 15 May 2026

The Market Is Missing the Bigger Picture on This Undervalued Stock - Morningstar

<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxQSjRFejR6UERrUTVETFR2T1ZfbGw3eDMtcFFTQ1RZZ0dfakpuQm9nRUQ2eHhGbWo2QzdyNlk1RjktbFM2cktjQ2FyMWc0eGJTc0RBeWZFcGI3RjdEUXJTeFVsaG1fYnc5UU9nMFVfdU83cVJnMC1QQm9sbkNBSHQ1UWdyMTRHU25uTGxhbT…

Google News Sun, 12 Jul 2026

Ecolab: A 2030 Growth Story The Market Is Paying For In 2026 (NYSE:ECL) - Seeking Alpha

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNOUFsQWxXdkhCSTFWblpsMllTMEdlM1B1UXlUSXdrdFhTdlF1QmZFeU9YemZZeXJDYnh0dkRabmh1NVBKWVpEa0JwTi1Ob0lSM2tWclVTRklBZ09EdHJKWTJRejU2c3FCRmZCb1p5dFA1YkVRczJpRk16aEpKYUpBZUdyWHgxTGt5dzh1cW…

Google News Sat, 14 Mar 2026

ECL Stock Falls -11% In 10-Day Spree On Margin Pressure Fears - Trefis

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxOamtDN2x0bnRXdUE4SVV0cUtpb2NiU2Z6bXFReGFwWTAwNXRmMTU2clVIRE5vdkVIcVBiOHo2eEJtOFk1S3ZSOU80SHZLMHF5UnpQc2pLR2dRSGtNRmdMbG96REZSYnNCTFBIWThIaktLRmJjOVhIeXRVT05aQ28zOEpqdXptNV9LMFVZdE…

Google News Wed, 08 Jul 2026

Ecolab Inc (ECL) Shares Fall 3.2% -- GF Value Says Still Overval - GuruFocus

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPVUtORjJCM0VFVGJIRFByaFFVMUZ4VElnMl9RY1l5c2NjQ0FrNmtONjFiMkthbHRiQVp1bmN5VzlzYXRNUUVtdFZ2NktLUzc1dUJkME01TGhTa1JrVkJuTkZobkR1N1hFOHliYTdheGRLcVUzUlAtTkZfYXlBU254d2J1U1dvblkycG5tZk…

ECL — Frequently Asked Questions

What is the current share price of Ecolab Inc. (ECL)?

As of 2026-07-14 21:23 PDT, Ecolab Inc. (ECL) trades at $269.75 on NYSE. Its 52-week range is $245.06 to $306.69.

What is the market capitalisation of ECL?

Ecolab Inc. (ECL) has a market capitalisation of $75.92B on NYSE.

What is the P/E ratio of ECL?

ECL trades at a trailing price-to-earnings (P/E) ratio of 36.55. The industry average P/E is 22.91. Its price-to-book (P/B) ratio is 7.47.

Does ECL pay a dividend?

Ecolab Inc. (ECL) currently offers a dividend yield of 1.10%.

What is the return on equity (ROE) of ECL?

ECL has a return on equity (ROE) of 22.43%. Its return on capital employed (ROCE) is 14.29%.

Is ECL a good stock to buy?

This page provides a data-driven analysis of Ecolab Inc. (ECL), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Ecolab Inc. ECL SPX

Company Overview

Why Investors Should Care

Recent Developments

Growth & Price Performance

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Price Chart

Technical Trend

Fundamental Growth Charts

PROS

CONS

Valuation

Growth (CAGR)

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Ecolab (ECL) Stock Looks 30% Overvalued Despite AI Cooling Deal - Yahoo Finance

Ecolab (ECL) Stock Looks Pricey On Cash Flow And Earnings - simplywall.st

The Market Is Missing the Bigger Picture on This Undervalued Stock - Morningstar

Ecolab: A 2030 Growth Story The Market Is Paying For In 2026 (NYSE:ECL) - Seeking Alpha

ECL Stock Falls -11% In 10-Day Spree On Margin Pressure Fears - Trefis

Ecolab Inc (ECL) Shares Fall 3.2% -- GF Value Says Still Overval - GuruFocus

ECL — Frequently Asked Questions

What is the current share price of Ecolab Inc. (ECL)?

What is the market capitalisation of ECL?

What is the P/E ratio of ECL?

Does ECL pay a dividend?

What is the return on equity (ROE) of ECL?

Is ECL a good stock to buy?

Explore More